Sageworth Trust CO Amgen Inc Transaction History

Sageworth Trust CO

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $112,443 - $137,049	498 Added 436.84%	612 $147,000
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $916 - $1,164	4 Added 3.64%	114 $30,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $9,228 - $10,269	-40 Reduced 26.67%	110 $27,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $8,770 - $9,702	-40 Reduced 21.05%	150 $36,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $315,857 - $370,065	-1,488 Reduced 88.68%	190 $40,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $296,179 - $328,589	1,268 Added 309.27%	1,678 $409,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $13,092 - $15,257	-59 Reduced 12.58%	410 $102,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $46,305 - $55,141	214 Added 83.92%	469 $108,000
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $17,364 - $19,310	74 Added 40.88%	255 $65,000
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $1,186 - $1,456	6 Added 3.43%	181 $43,000
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $33,111 - $42,560	175 New	175 $42,000
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $13,580 - $16,272	-78 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $75,681 - $88,716	-454 Reduced 85.34%	78 $14,000
Q1 2019 Apr 08, 2019	BUY	$180.87 - $203.88 $95,318 - $107,444	527 Added 10540.0%	532 $101,000
Q4 2018 Jan 18, 2019	SELL	$178.4 - $208.25 $32,290 - $37,693	-181 Reduced 97.31%	5 $1,000
Q3 2018 Oct 30, 2018	BUY	$185.29 - $208.89 $34,463 - $38,853	186 New	186 $39,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.